RISK FACTORS FOR THE DEVELOPMENT OF INHIBITOR FORMS OF HEMOPHILIA
https://doi.org/10.51523/2708-6011.2011-8-4-16
Abstract
The aim of the work was a complex assessment of inhibitor forms of hemophilia with the account of patients` age, severity of the disease and variant of hemophilia. The article presents the results of the examination of 47 patients with hemophilia in the presence of the inhibitors to plasmic factors of blood coagulation. 97,5 % patients with hemophilia A and 100 % of the examined patients with hemophilia B revealed a diagnostically considerable increase of the inhibitor level (> 0,6BU/ml). The majority of the patients with hemophilia A and hemophilia B (64 и 86 % correspondingly) diagnosed a mild inhibitor form. The development of the inhibitor form of hemophilia in general did not depend on the patients` age, level of factor deficiency and variant of hemophilia. The plan of dynamic observation of the patients with the inhibitor form has been suggested.
About the Authors
S. A. Hoduleva
Gomel State Medical University
Belarus
Belarus
A. A. Hoteyeva
Gomel State Medical University
Belarus
Belarus
References
1. Данилов, И. П. Гемофилия: эпидемиология, клиника, терапия / И. П. Данилов, А. Л. Усс, Д. Г. Цвирко // Медицинская панорама. - 2002. - № 2. - С. 73-76.
2. Ингибиторы при гемофилии А. Часть 1. Механизмы ингибирования фактора VIII / Н. М. Ананьева [и др.] // Гематология и трансфузиология. - 2005. - Т. 50, № 2. - С. 56-53.
3. Charles, R. M. The epidemiology of factor VIII inhibitors / R. M. Charles // Haemophilia. - 2006. - Vol. 12. - P. 23-29.
4. Wight, J. The epidemiology of inhibitors in haemophilia A: a systematic review / J. Wight, S. Paisley // Haemophilia. - 2003. - Vol. 9. - P. 418-435.
5. Андреев, Ю. И. Ингибиторная форма гемофилии / Ю.И. Андреев // Врач. - 2001. - № 10. - С. 8-12.
6. Franchini, N. Inhibitors in mild/moderate haemophilia A: An update / N. Franchini, G. L. Salvagno, G. Lippi // Thrombosis and Haemostasis. - 2006. - Vol. 96. - P. 113-118.
7. Dargaud, Y. New advances in the therapeutic and laboratory ma-nagement of patients with haemophilia and ingibitors / Y. Dargaud, T. Lam-bert, M. Trossaert // Haemophilia. - 2008. - Vol. 14, Is. 4. - P. 20-27.
Review
For citations:
Hoduleva S.A., Hoteyeva A.A. RISK FACTORS FOR THE DEVELOPMENT OF INHIBITOR FORMS OF HEMOPHILIA. Health and Ecology Issues. 2011;(4):92-95. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-4-16
Views: 402
Email this article 